Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / @xirurgi_2025 / @xirurgi_2025 - 881 - файл

.pdf
Скачиваний:
0
Добавлен:
29.08.2026
Размер:
9 Мб
Скачать
390
S. Sandrucci
asymptomatic until the mass reaches a large size (often 15cm or greater). Symptoms include a palpable mass, early satiety, abdominal discomfort, or occasionally a new varicocele in men. Others may be incidental ndings during abdominal imaging for other reasons.
Retroperitoneal sarcomas are distinct from other soft tissue sarcomas, in that local recurrence, rather than distant metastasis, is the most common cause of disease- specic mortality, accounting for 75% of deaths [21]. Extended surgical resections, encompassing adjacent uninvolved organs, have been adopted by several sarcoma centers with the aim of improving local control and patient outcomes [21,
22]. Compared to limited resections, extended resections have been shown to
improve oncological outcomes (60% of patients surviving 5years) with an accept­able perioperative morbidity.
Proper resection of RPS requires appreciation of the anatomic boundaries of the tumor [23]. CT imaging should be reviewed to identify landmarks dening the extent of the mass to determine which structures may be safely resected and which ones cannot. The anterior margin of a RPS is generally the ipsilateral colon and mesocolon, pancreas, liver, or stomach. The posterior margin is generally the psoas and iliacus muscles inferiorly, the ipsilateral kidney and diaphragm superiorly, and the ipsilateral ureter and gonadal vessels medially. However, this may vary from tumor to tumor, and some or all of these structures could be anterior to the mass, in which case they would constitute a portion of the anterior margin. The medial mar­gin usually includes the spine and paraspinous muscles, the inferior vena cava (for right-sided tumors), and the aorta (for left-sided tumors). The lateral margin is con­stituted by the lateral or ank musculoskeletal sidewall, although depending on the size and location of the tumor, the kidney and/or colon could also border the lateral portion of the mass. The superior margin is similarly dependent on the size and location of the mass and may include the diaphragm on either side; the right lobe of the liver, the duodenum, and the head/uncinate process of the pancreas for right­sided tumors; and pancreatic tail, spleen, and splenic vessels for left-sided tumors. The inferior margin may include the iliopsoas muscle; the femoral nerve; the com­mon, internal, and external iliac vessels; and the pelvic sidewall [21]. Clearly, the size and specic location of the mass determine which of the many structures men­tioned above constitute which specic margin.
In general, the ipsilateral kidney, colon and mesocolon, and at least a portion of the psoas can be safely and relatively easily resected without much difculty. Resection of the pancreatic tail and spleen can usually be performed with relatively low short-term morbidity. Resection of other structures, including but not limited to the aorta, inferior vena cava, iliac vessels, femoral nerve, diaphragm, duodenum, pancreatic head or uncinate process, and liver, entails more signicant resections, with ensuing greater morbidity [24].
The proportion of elderly patients that are t for extended resections at presenta­tion and the outcomes of surgery in this age group is unknown. A surgical approach is still potentially benecial in the elderly, as life expectancy is over 10years in people of 75years of age of either sex and does not fall below 5years until beyond the age of 85years [19].
27 The Management ofSoft Tissue Sarcoma intheElderly
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
391
However, extended resections for retroperitoneal sarcoma are a substantial undertaking. The proportion of patients treated nonoperatively is signicantly higher in those aged over 65years, with no difference in the proportion of patients presenting with unresectable disease between older and younger patients, due to unsuitability to major surgical intervention for comorbidities or surgery refusal. Perioperative morbidity has a threefold increase in patients over 65years, but peri­operative mortality does not increase compared to younger patients, and no evidence exists in identifying age as a prognostic factor [20, 25].
The location, rather than the absolute size, of retroperitoneal sarcomas is most pertinent in determining resectability, with the median tumor size in patients unsuit­able for surgery being on average smaller than those proceeding to operation. In case of established renal insufciency, the tumor must be deemed to be inoperable, as resection would necessitate a nephrectomy, which would likely render the patient dialysis dependent. Renal replacement therapy has not been shown to improve sur­vival in the elderly when comorbidities are taken into account, and the median sur­vival of elderly patients on dialysis is approximately 3years [19, 24]. As such, it becomes difcult to justify an extended resection that is likely to result in end-stage renal failure, although these decisions should be made on a case-by-case basis.
The outcomes for patients managed nonoperatively are poor. The use of radio­therapy or chemotherapy is signicantly less common in patients older than 65years, likely reecting the proportion of patients unt for operative management. Due to the lack of effective treatment options in this situation, the patient’s quality of life should be paramount in treatment planning.
27.3 Adjuvant/Neoadjuvant Radiation
Therapy andChemotherapy
Postoperative chemo-/radiotherapy has no proven efcacy in retroperitoneal sarco­mas [26].
Limb-sparing surgery generally relies on adjuvant/neoadjuvant radiation therapy to minimize risk of local recurrence. The goal of radiation is to treat the margin to minimize the risk of recurrence, not necessarily to reduce the size of the tumor per se. Radiation therapy reduces the risk of local recurrence from greater than 30% to less than 10% in most series, but does not impact distant failure or overall survival [27].
Radiation therapy may be delivered as external beam radiation therapy (EBRT) or brachytherapy. EBRT may be delivered preoperatively or postoperatively. Preoperative EBRT is associated with a doubling in the rate of wound complications (35% vs. 17%) but importantly with a lower rate of late complications and tissue brosis and better functional outcomes. Postoperative EBRT generally has higher dose than preoperative EBRT.Brachytherapy may be delivered through afterloading catheters placed across the tumor bed at the end of surgery. The goal of brachy­therapy is to deliver additional radiation to a close margin (including neurovascular structures) with minimal treatment to surrounding tissue, particularly when further EBRT is no longer feasible. This can be a desirable option for older patients.
392
Approximately 25–50% of patients with extremity STS develop distant meta­static disease [28]. Those with large (>10cm), deep, high-grade STS may be con­sidered for preoperative or postoperative chemotherapy, usually with active agents such as doxorubicin and ifosfamide (response rates of 20–40% in patients with metastatic disease). However, there are no consistently convincing data that such an approach improves overall survival for most STS histologies, and cardiac and kid­ney toxicities make the majority of older patients unt for treatment.
Hyperthermic isolated limb perfusion (ILP) and infusion (ILI) have been inves­tigated in several institutions as treatment for patients with locally advanced STS in whom limb-sparing, function-sparing surgery may not be possible, but the associ­ated high morbidity makes this treatment not advisable for geriatric patients [29].
S. Sandrucci
27.4 Histology-Specific Treatments
27.4.1 Atypical Lipomatous Tumor (ALT)/
Well-Differentiated Liposarcoma
This low-grade tumor, when arising in the extremity, has a relatively low rate of recurrence, may not recur for quite some time, and has no risk of distant metastatic spread and death, unless dedifferentiation occurs over its natural history. Dedifferentiation, if it occurs, in fact entails a risk of metastatic spread as high as 20%. In contrast, low-grade locally recurrent ALT may grow slowly for years. Therefore, such tumors arising in the extremity can be resected with a limited nega­tive or even a positive margin especially when preserving limb function is an issue. Radiographically, ALT may be difcult to distinguish from an intramuscular lipoma, a benign entity which can also arise in deep muscle tissue. ALT/well-differentiated liposarcoma is a more threatening neoplasm when located in the retroperitoneum even in the absence of areas of dedifferentiation. In fact, local control is an issue at this site, and patients often die of locoregional failure, without developing distant metastases [2, 21].
27.4.2 Dermatofibrosarcoma Protuberans (DFSP)
DFSP is a supercial tumor which inltrates soft tissue for centimeters beyond the obvious margins of the lesion and can recur locally following an inadequate resec­tion. However, the more common variety of DFSP does not display metastatic behavior. Therefore, the goal of surgery should be negative margins, often necessi­tating reconstruction by plastic surgery. When cosmesis or function preservation is an issue, limited positive margins may be accepted, and a wider resection postponed until DFSP locally recurs.
Since DFSP is usually a relatively supercial tumor, resection of muscle deep to the tumor is not often necessary. Intraoperative frozen section margin analysis is not generally helpful, as the surrounding fat rarely freezes well for analysis. Radiation
27 The Management ofSoft Tissue Sarcoma intheElderly
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
393
therapy is not usually recommended. Approximately 5–10% of patients with DFSP have a more aggressive brosarcomatous variant which may recur locally and potentially spread. Those individuals should be treated as a “conventional” sarcoma with more aggressive local therapy (including radiation) and followed with system­atic imaging.
27.4.3 Myxofibrosarcoma
Myxobrosarcoma most commonly arises in the extremities of elderly individuals. It demonstrates a 30% rate of local recurrence and 16% rate of distant recurrence [14]. Multiple local recurrences have been associated with eventual amputation. Therefore, it is critical to pursue aggressive local therapy. Wide surgical margins (2–4cm radial margins beyond the clinical boundaries of the palpable mass, especially in more supercial tumors) should be the goal of surgery, which often requires complex wound closure or ap reconstruction by a plastic and reconstructive surgeon, as well as resection and reconstruction of vessels and/or nerves. Radiation therapy, either preoperatively or postoperatively (described below), may be considered, though the direct impact on this specic histology remains unknown.
27.4.4 Angiosarcoma
Scalp angiosarcomas are commonly multifocal, by both clinical examination and CT or MRI imaging. As radical surgery (often requiring complex ap reconstruc­tions) is possible but rarely curative even if margins are widely negative, it may be reserved for patients who are experiencing problems with local control (bleeding from a fungating tumor) or who only appear to have a solitary site of disease by both clinical examination and imaging while undergoing systemic therapy. Angiosarcoma is sensitive to systemic chemotherapy and to radiation therapy [2].
27.4.5 Radiation-Induced Sarcomas
Radiation-induced sarcomas are rare and include a variety of histological subtypes, the most common of which are unclassied pleomorphic sarcoma, angiosarcoma, malignant peripheral nerve sheath tumors, and leiomyosarcoma. Besides the intrin­sic characteristics of each histological subtype, they are all characterized by a high propensity to locally recur, given the difculty of obtaining clear margins. This is due in part to the difculty in distinguishing tumor inltration of healthy tissues from radiation-induced soft tissue changes around the tumor site and in part to the discontiguous and multifocal involvement of tissue within the radiation eld. The tumor should be excised with as much tissue around it as possible. This often if not always requires reconstruction and coverage by a plastic surgeon and potentially a more liberal policy of neurovascular resection and reconstruction. Systemic
394
S. Sandrucci
chemotherapy and re-irradiation are often considered, given the overall dismal prognosis, though the use of the latter must be weighed with caution [2].
References
1. Stiller CA, Trama A, Serraino D, Rossi S, Navarro C, Chirlaque MD, RARECARE Working
Group, etal. Descriptive epidemiology of sarcomas in Europe: report from the RARECARE project. Eur J Cancer. 2013;49(3):684–95.
2. Samuel LC. Bone and soft tissue sarcomas. In: Yarbro CH, Wujcik D, Gobel BH, editors.
Cancer nursing: principles and practice. 8th ed. Burlington: Jones &Bartlett Learning; 2018. (chapter 46).
3. Ray-Coquard I, Thiesse P, Ranchère-Vince D, Chauvin F, Bobin JY, Sunyach MP, et al.
Conformity to clinical practice guidelines, multidisciplinary management and outcome of treatment for soft tissue sarcomas. Ann Oncol. 2004;15(2):307–15.
4. The ESMO/European Sarcoma Network Working Group. Soft tissue and visceral sarco-
mas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014;25(Suppl 3):iii102–12.
5. von Mehren M, Randal RL, Benjamin RS, Boles S, Bui MM, Conrad EU, etal. Soft tissue
sarcoma, version 2.2016, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2016;14(6):758–86.
6. Noebauer-Huhmann IM, Weber MA, Lalam RK, Trattnig S, Bohndorf K, Vanhoenacker F,
etal. Soft tissue tumors in adults: ESSR-approved guidelines for diagnostic imaging. Semin Musculoskelet Radiol. 2015;19(5):475–82.
7. Preston SD, Southall AR, Nel M, Das SK.Geriatric surgery is about disease, not age. J R Soc
Med. 2008;101:409–15.
8. Canter RJ.Surgical approach for soft tissue sarcoma: standard of care and future approaches.
Curr Opin Oncol. 2015;27(4):343–8.
9. Honoré C, Méeus P, Stoeckle E, Bonvalot S.Soft tissue sarcoma in France in 2015: epidemiol-
ogy, classication and organization of clinical care. J ViscSurg. 2015;152(4):223–30.
10. Paredes T, Pereira M, Simões MR.A longitudinal study on emotional adjustment of sarcoma
patients: the determinant role of demographic, clinical and coping variables. Eur J Cancer Care. 2012;21(1):41–51.
11. Enneking WF, Spanier SS, Goodman MA.A system for the surgical staging of musculoskel-
etal sarcoma. Clin Orthop Relat Res. 1980;153:106–20.
12. Stoeckle E, Italiano A, Stock N, Kind M, Kantor G, Coindre JM, Bui BN.Surgical margins in
soft tissue sarcoma. Bull Cancer. 2008;95(12):1199–204.
13. Gerrand CH, Wunder JS, Kandel RA, etal. Classication of positive margins after resection
of soft tissue sarcoma of the limb predict the risk of local recurrence. J Bone Joint Surg Br. 2001;83:1149–55.
14. Haglund KE, Raut CP, Nascimento AF, Wang Q, George S, Baldini EH.Recurrence patterns
and survival for patients with intermediate- and high-grade myxobrosarcoma. Int J Radiat Oncol Biol Phys. 2012;82(1):361–7.
15. Brooks A, Gold J, Graham D, etal. Resection of the sciatic, peroneal or tibial nerves: assess-
ment of functional status. Ann Surg Oncol. 2002;9(1):41–7.
16. Rosemberg SA, Tepper J, Glatsein E, etal. The treatment of soft tissue sarcomas of the extrem-
ities; prospective evaluations of limb sparing surgery plus radiation therapy compared with amputation and the role of adjuvant chemotherapy. Ann Surg. 1982;196:305–15.
17. Hassan S, Gale J, Perks A, etal. Reconstruction and nancial remuneration following soft tis-
sue sarcoma surgery. Bull R Coll Surg Engl. 2013;95(5):160–2.
18. Venkasetan M, Richards CJ, McCullack TA, etal. Inadvertent surgical resection of soft tissue
sarcomas. Eur J Surg Oncol. 2012;38:346–51.
27 The Management ofSoft Tissue Sarcoma intheElderly
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
395
19. Smith HG, Thomas JM, Smith MJ, etal. Multivisceral resection of retroperitoneal sarcomas in
the elderly. Eur J Cancer. 2016;69:119–26.
20. Porter GA, Baxter NN, Pisters PW.Retroperitoneal sarcoma: a population-based analysis of
epidemiology, surgery, and radiotherapy. Cancer. 2006;106:1610–6.
21. Gronchi A, Miceli R, Allard MA, Callegaro D, Le Péchoux C, Fiore M, etal. Personalizing the
approach to retroperitoneal soft tissue sarcoma: histology-specic patterns of failure and post relapse outcome after primary extended resection. Ann Surg Oncol. 2015;22(5):1447–54.
22. Bonvalot S, Raut CP, Pollock RE, etal. Technical considerations in surgery for retroperito-
neal sarcomas: position paper from E-surge, a master class in sarcoma surgery, and EORTC­STBSG.Ann Surg Oncol. 2012;19(9):2981–91.
23. Anaya DA, Lev DC, Pollock RE.The role of surgical margin status in retroperitoneal sarcoma.
J Surg Oncol. 2008;98:607–10.
24. Smith HG, Panchalingam D, Hannay JA, Smith MJ, Thomas JM, Hayes AJ, etal. Outcome
following resection of retroperitoneal sarcoma. Br J Surg. 2015;102:1698–709.
25. Berger NA, Savvides P, Koroukian SM, Kahana EF, Deimling GT, Rose JH, etal. Cancer in the
elderly. Trans Am Clin Climatol Assoc. 2006;117:147–55.
26. Casali PG.Adjuvant chemotherapy for soft tissue sarcoma. Am Soc Clin Oncol Educ Book.
2015;35:e629–33.
27. Haas RL, Delaney TF, O’sullivan B, Keus RB, Le Pechoux C, Olmi P, etal. Radiotherapy for
management of extremity soft tissue sarcomas: why, when, and where? Int J Radiat Oncol Biol Phys. 2012;84(3):572–80.
28. Coindre JM, Terrier P, Guillou L, Le Doussal V, Collin F, Ranchère D, etal. Predictive value of
grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group. Cancer. 2001;91(10):1914–26.
29. Jakob J, Hohenberger P. Role of isolated limb perfusion with recombinant human tumor
necrosis factor α and melphalan inlocally advanced extremity soft tissue sarcoma. Cancer. 2016;122(17):2624–32.
30. Sanlippo R, Miceli R, Grosso F, et al. Myxobrosarcoma: prognostic factors and survival in
a series of patients treated at a single institution. Ann Surg Oncol. 2011;18(3):720–5.
Part VII
Trauma and Non Traumatic Emergencies
Trauma inGeriatric Age
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
28
EmanueleRausa, FedericoCoccolini, GiuliaMontori, Maria AgneseKelly, BaggiPaolo, DarioPiazzalunga, CeciliaMerli, andLucaAnsaloni
28.1 Introduction
The denition of the word “elderly” is not one that has been universally agreed though it is generally accepted that it pertains to a subset of population between 45 and 75years old [1]. People are living much longer worldwide. Currently, the popu­lation over 60years of age accounts for over 40 million persons in the United States. Over the next 20years, the population over 65years of age is projected to double in size, reaching 82.3 million (approximately 22% of the total population) by 2040 [2].
It is thought that the population over 65years of age will be the fastest growing subset of population. As this population grows, so too will the need for healthcare services and their costs. In 2008, despite the fact that the elderly constituted only 13% of the US population, they represented 40% of all hospitalized adults. The total expenditure on health care reects these data; in fact, the elderly costs twice as much as their younger counterparts (13.2% vs 6.6%, respectively) [3].
The Western lifestyle encourages old people to maintain their independence for as long as possible. In 2014, there were 5709 people over 65 killed and an estimated 221,000 injured in motor vehicle trafc crashes. Older people made up 17 percent of all trafc fatalities and 9% of all people injured in trafc crashes during the year [4].
However, physiological changes are natural and uncontrolled events that affect compensatory mechanisms and cause them to become insufcient to adequately
E. Rausa • F. Coccolini • G. Montori • B. Paolo • D. Piazzalunga • L. Ansaloni (*) Unit of General and Emergency Surgery, Papa Giovanni XXIII Hospital, P.zza OMS 1, 24128 Bergamo, Italy e-mail: lansaloni@asst-pg23.it
M.A. Kelly Department of Colorectal Diseases, St. Vincent’s University Hospital, Elm Park, Dublin, Ireland
C. Merli Unit of Emergency Medicine, Papa Giovanni XXIII Hospital, Bergamo, Italy
© Springer International Publishing AG, part of Springer Nature 2018 A. Crucitti (ed.), Surgical Management of Elderly Patients,
https://doi.org/10.1007/978-3-319-60861-7_28
399
400
E. Rausa et al.
react to injuries, illnesses, or surgery [5]. This physiological decline renders the elderly prone to traumatic injuries in the course of their daily activities. Furthermore, the higher comorbidities rate (66%) and preexisting home therapy may exacerbate and complicate the trauma and the underlying physiological mechanism [6].
The trauma mechanism in the elderly is dissimilar to that in their younger coun­terparts. In young patients, road trauma is most prevalent (58.4%). Other predomi­nant trauma mechanisms are recreation (15.4%) and violence (15.3%) [7].
Blunt trauma is the dominant mechanism in elderly patients (EPs) and makes up more than 80% of all geriatric trauma [8]. Falls, which consist of a low-energy blunt trauma, account for 70% of blunt trauma cases. EPs may be more inclined to fall because of physiological change with aging and comorbidities affecting the muscu­loskeletal system and the brain causing tremor, rigidity, and dementia. Further blunt trauma events are motor vehicle accidents (the second most common trauma mech­anism), pedestrian struck, and burn injuries [9]. Finally, there are penetrating trauma and suicide attempts. EPs account for 18% of all suicide deaths. Of note, domestic abuse and assaults represent an underrated cause of trauma, with an estimated 25,886 elderly people treated in emergency departments for lacerations, contusions, or fractures secondary to nonfatal assaults. It is estimated that roughly 85% of abuse incidents involving the elderly are not reported [10].
Despite the steady increase in geriatric trauma admissions, specic guidelines addressed toward the management of the geriatric have not been dened, and the treatment remains challenging. Demetriades etal. showed a deciency in the proper triaging of these trauma cases [11]. EPs, even if severely injured, were underrated in 25% of cases. This bias results in a signicant delay in treatment. Statistics show that 43% of patients who were considered hemodynamically stable were found to have experienced cardiogenic shock, and 54% of these cases resulted in death [12]. Mortality among those patients was substantially reduced by employing “age over 70” as an activation code for the trauma team [11].
Given the well-established relationship between age, Injury Severity Score (ISS), and mortality, a clear trauma classication at the presentation is essential as invasive procedures in EPs are widely accepted in ISS>18, whereas in ISS<18, the indica­tions need to be cautiously evaluated according to the risks and benets [13].
Due to a reduced physiological reserve, body reaction to a traumatic event is poor in both the short and the long term. EPs who are hospitalized are likely to develop a limitation in their daily abilities and functional status and need long-term care. A poor pre-injury functional status is a strong predictor of an undesirable out­come [14]. It has been evaluated as even more relevant than the admitting diagnosis in the short term (complications and in-hospital mortality) and the long term (post­hospitalization mortality) [15].
Poor functional status at the baseline, an advanced age, and a high ISS result in a longer hospital stay and increase the risk of developing nosocomial infections. As shown by Labib etal., among all the nosocomial complications, respiratory compli­cations are those that most increase the risk for in-hospital mortality [16]. Pracht etal. showed that in patient groups aged between 65 and 74years of age, the risk of mortality increases according to the number of comorbidities [17].
28 Trauma inGeriatric Age
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
401
Fleischman etal. show that age is a relevant predictor of long-term prognosis. In fact, the risk of post-hospitalization mortality continues to go up until 6months post-trauma in EPs [18]. Additionally, Davidson etal. stated that the risk of post- hospitalization mor­tality remains high over a 3-year post-trauma period (16%) [19]. EPs outcomes are related to multiple signicant factors such as trauma mechanism, age, ISS, comorbidi­ties (especially cardiovascular comorbidities), functional status at the baseline, and home therapy [20]. In this context, as EPs are extremely frail and feeble, it would be better to evaluate them more as individuals than as a cohort of patients.
28.2 The Physiology ofAging
Substantial physiological changes occur in aging and may affect the body’s response to trauma.
In a trauma, the rst body reaction is the release of catecholamine hormones, in order to raise blood pressure and provide more blood to muscles and brain. In EPs, the cardiovascular system responds to this stimulation with a consistent delay [21].
Additionally, medications such as beta-blockers or diuretic medications may miti­gate the hormones’ effect and exacerbate a forced status of hypotension and hypoper­fusion in cases of blood loss. Figures which dene the “normal blood pressure” in adults should be reconsidered in EPs. Heffernan etal. found that mortality increased in EPs with a systolic blood pressure <110mmHg, whereas the same results were obtained when the blood pressure was <95mmHg in younger counterparts [22].
The heart and vessels are stiff and thickened, causing a decreased compliance. Body uid compartments are extremely narrow, and small changes among them coincide with a massive change between hypovolemia and edema because cardiac reserve is limited; atherosclerosis leads to poor vessel constriction, and the neuro­logical system is slow in arousing the “ght or ight” response [23].
In a trauma, EPs may decompensate quickly because the respiratory reserve is decreased as well. The loss in elasticity and arthritic process makes the rib cage stiff, causing a reduction in the articular range of motion. Lungs, which are enclosed in an inexible space, lose compliance, and the vital capacity decreases, while the dead space increases. Additionally, the pulmonary tissue changes its pattern because of brosis and the loss of collagen and because of chemicals and pollution in the atmosphere. Hence, early intubation is recommended in patients with borderline respiratory function [
The kidneys are less efcient in concentrating urine. Even temporary hypoten­sion and hypoperfusion, radiological contrast, or nephrotoxic drugs represent a trig­ger for an acute kidney injury [25]. Aging acts on the musculoskeletal system, decreasing the muscle mass and strength because fat or brous tissue replaces mus­cles. In addition, osteoporosis and arthritis decrease bone density and make EPs susceptible to fracture, even in low-energy trauma [26].
Finally, another substantial physiological change is the loss of adequate thermo­regulation. Even a modest trauma may easily make EPs hypothermic, resulting in a worsening of coagulopathy, which then dramatically raises the risk of mortality [27].
24].